Trichloroacetic Acid Peel of Molluscum Contagiosum in Immunocompromised Patients

STEVEN J. GARRETT, JUNE K. ROBINSON*, HENRY H. ROENIGK

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

46 Scopus citations

Abstract

Seven human immunodeficiency virus‐(HIV) positive patients with biopsy proved extensive facial molluscum contagiosum were treated with trichloroacetic acid peels. Peels were performed with 25 to 50% trichloroacetic acid (average 35%) and were repeated every 2 weeks as needed. A total of 15 peels were performed with an average reduction in lesion counts of 40.5% (range 0 to 90%). No spread of molluscum lesions, scarring, or secondary infection developed at 2 months' follow‐up. Trichloroacetic acid peeling in concentrations of 35% or less appears to be a safe, effective, adjuvant therapy in the treatment of extensive molluscum contagiosum in immunocompromised patients. 1992 American Society for Dermatologic Surgery, Inc.

Original languageEnglish (US)
Pages (from-to)855-858
Number of pages4
JournalThe Journal of Dermatologic Surgery and Oncology
Volume18
Issue number10
DOIs
StatePublished - Oct 1992

ASJC Scopus subject areas

  • Dermatology
  • Oncology

Fingerprint

Dive into the research topics of 'Trichloroacetic Acid Peel of Molluscum Contagiosum in Immunocompromised Patients'. Together they form a unique fingerprint.

Cite this